(Q36959139)

17 August 2017

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles (English)

1 reference

prostate cancer screening

17 August 2017

1 reference

B Małkiewicz

15

0 references

Janusz Menkiszak

J Menkiszak

19

0 references

Marcin Słojewski

M Słojewski

6

0 references

Anna Jakubowska

A Jakubowska

22

0 references

Cezary Cybulski

1

C Cybulski

1 reference

17 August 2017

29

J Lubiński

1 reference

17 August 2017

Artitaya Lophatananon

28

A Lophatananon

1 reference

17 August 2017

27

K R Muir

1 reference

17 August 2017

30

S A Narod

1 reference

Polish Hereditary Prostate Cancer Consortium

17 August 2017

31

Polish Hereditary Prostate Cancer Consortium

1 reference

17 August 2017

21

J Gronwald

1 reference

17 August 2017

26

T Huzarski

1 reference

17 August 2017

23

B Górski

1 reference

17 August 2017

2

D Wokołorczyk

1 reference

17 August 2017

24

T Dębniak

1 reference

17 August 2017

25

B Masojć

1 reference

17 August 2017

W Kluźniak

3

1 reference

17 August 2017

A Kashyap

4

1 reference

17 August 2017

A Gołąb

5

1 reference

17 August 2017

A Sikorski

7

1 reference

17 August 2017

M Puszyński

8

1 reference

17 August 2017

M Soczawa

9

1 reference

17 August 2017

T Borkowski

10

1 reference

17 August 2017

A Borkowski

11

1 reference

17 August 2017

A Antczak

12

1 reference

17 August 2017

J Przybyła

13

1 reference

17 August 2017

M Sosnowski

14

1 reference

17 August 2017

R Zdrojowy

16

1 reference

17 August 2017

P Domagała

17

1 reference

17 August 2017

K Piotrowski

18

1 reference

17 August 2017

K Krzystolik

20

1 reference

17 August 2017

language of work or name

English

0 references

publication date

30 May 2013

1 reference

British Journal of Cancer

17 August 2017

1 reference

17 August 2017

108

1 reference

17 August 2017

12

1 reference

17 August 2017

2601-2609

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2013.261

17 August 2017

0 references

cites work

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Screening for prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

An inherited NBN mutation is associated with poor prognosis prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Germline BRCA1 mutations increase prostate cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Germline mutations in HOXB13 and prostate-cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Rapid progression of prostate cancer in men with a BRCA2 mutation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

A large germline deletion in the Chek2 kinase gene is associated with an increased risk of prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

CHEK2 variants associate with hereditary prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Mutations in CHEK2 associated with prostate cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Screening for prostate cancer: estimating the magnitude of overdetection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Study of a single BRCA2 mutation with high carrier frequency in a small population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Early detection of prostate cancer in African-American men with an increased familial risk of disease.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

A screening study of prostate cancer in high risk families

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

A common variant associated with prostate cancer in European and African populations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

BRCA2 mutation in Icelandic prostate cancer patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Genetic variants associated with predisposition to prostate cancer and potential clinical implications

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Multiple loci on 8q24 associated with prostate cancer susceptibility.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Screening for prostate cancer in Dutch hereditary prostate cancer families.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

NBS1 is a prostate cancer susceptibility gene.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Family history and prostate cancer screening with prostate-specific antigen

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3694242

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

4 September 2018

2 references

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2013.261

21 January 2018

12 December 2020

The contribution of founder mutations to early-onset breast cancer in French-Canadian women

1 reference

12 December 2020

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

1 reference

12 December 2020

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives

1 reference

12 December 2020

Screening for prostate cancer in high risk populations

1 reference

12 December 2020

The impact of family history on early detection of prostate cancer

1 reference

12 December 2020

The European Randomized Study of Screening for Prostate Cancer (ERSPC)

1 reference

12 December 2020

Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families

1 reference

12 December 2020

Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic

1 reference

12 December 2020

Cumulative association of five genetic variants with prostate cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2013.261

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

1 reference